Brief: Clover Biopharmaceuticals Does Not See Meaningful Financial Contribution From Covid Vaccine Sales In 2023

Clover Biopharmaceuticals

11/07/2023 24:27

July 11 (Reuters) - Clover Biopharmaceuticals Ltd
 2197.HK :
    * COMPANY DOES NOT EXPECT MEANINGFUL FINANCIAL CONTRIBUTION
FROM
COVID-19 VACCINE SALES IN 2023
    * FURTHER ANTICIPATES AT LEAST ONE ADDITIONAL IN-LICENSING
DEAL IN
2023 TO EXPAND ITS MID- TO LATE-STAGE PIPELINE
    * COMPANY IS DEVELOPING AN UPDATED VERSION OF ITS COVID-19
VACCINE
INCLUDING XBB.1.5 VARIANT

Source text for Eikon:  ID: 
Further company coverage:  2197.HK 

 ((Reuters.Briefs@thomsonreuters.com;))